0001615774-18-006001.txt : 20180629
0001615774-18-006001.hdr.sgml : 20180629
20180629160429
ACCESSION NUMBER: 0001615774-18-006001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180627
FILED AS OF DATE: 20180629
DATE AS OF CHANGE: 20180629
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Guse Kyle
CENTRAL INDEX KEY: 0001566618
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35610
FILM NUMBER: 18929316
MAIL ADDRESS:
STREET 1: C/O ATOSSA GENETICS INC.
STREET 2: 1616 EASTLAKE AVE. E SUITE 510
CITY: SEATTLE
STATE: WA
ZIP: 98102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ATOSSA GENETICS INC
CENTRAL INDEX KEY: 0001488039
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264753208
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 107 SPRING STREET
CITY: SEATTLE
STATE: WA
ZIP: 98104
BUSINESS PHONE: 206.588.0256
MAIL ADDRESS:
STREET 1: 107 SPRING STREET
CITY: SEATTLE
STATE: WA
ZIP: 98104
4
1
s111134_form4.xml
4
X0306
4
2018-06-27
0
0001488039
ATOSSA GENETICS INC
ATOS
0001566618
Guse Kyle
C/O ATOSSA GENETICS INC.
107 SPRING STREET
SEATTLE
WA
98104
0
1
0
0
CFO, Gen Counsel and Secretary
Stock Option (right to buy)
2.38
2018-06-27
4
A
0
700000
0.00
A
2028-06-27
Common Stock
700000
700000
D
Twenty-five percent of the options have vested as of the grant date, 50% of the options will vest quarterly over two years, and the remaining 25% will vest upon achievement of certain milestones.
/s/ Kyle Guse
2018-06-29